JP6300030B2 - 2−((2s,3s,4r,5r)−5−((s)−3−アミノ−2−ヒドロキシプロプ−1−イル)−4−メトキシ−3−(フェニルスルホニルメチル)テトラヒドロフラン−2−イル)アセトアルデヒド誘導体およびこれらを調製するためのプロセス - Google Patents

2−((2s,3s,4r,5r)−5−((s)−3−アミノ−2−ヒドロキシプロプ−1−イル)−4−メトキシ−3−(フェニルスルホニルメチル)テトラヒドロフラン−2−イル)アセトアルデヒド誘導体およびこれらを調製するためのプロセス Download PDF

Info

Publication number
JP6300030B2
JP6300030B2 JP2014549284A JP2014549284A JP6300030B2 JP 6300030 B2 JP6300030 B2 JP 6300030B2 JP 2014549284 A JP2014549284 A JP 2014549284A JP 2014549284 A JP2014549284 A JP 2014549284A JP 6300030 B2 JP6300030 B2 JP 6300030B2
Authority
JP
Japan
Prior art keywords
compound
group
formula
silyl
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014549284A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015503525A (ja
Inventor
イー.エス. ソウザ,ファビオ
イー.エス. ソウザ,ファビオ
ルドルフ,アレナ
パン,ミン
ゴリン,ボリス
アルベリコ,ディノ
Original Assignee
サンド アクツィエンゲゼルシャフト
サンド アクツィエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サンド アクツィエンゲゼルシャフト, サンド アクツィエンゲゼルシャフト filed Critical サンド アクツィエンゲゼルシャフト
Publication of JP2015503525A publication Critical patent/JP2015503525A/ja
Application granted granted Critical
Publication of JP6300030B2 publication Critical patent/JP6300030B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2014549284A 2011-12-29 2012-12-24 2−((2s,3s,4r,5r)−5−((s)−3−アミノ−2−ヒドロキシプロプ−1−イル)−4−メトキシ−3−(フェニルスルホニルメチル)テトラヒドロフラン−2−イル)アセトアルデヒド誘導体およびこれらを調製するためのプロセス Expired - Fee Related JP6300030B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161581164P 2011-12-29 2011-12-29
US61/581,164 2011-12-29
PCT/CA2012/050939 WO2013097042A1 (en) 2011-12-29 2012-12-24 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
JP2015503525A JP2015503525A (ja) 2015-02-02
JP6300030B2 true JP6300030B2 (ja) 2018-03-28

Family

ID=48696142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014549284A Expired - Fee Related JP6300030B2 (ja) 2011-12-29 2012-12-24 2−((2s,3s,4r,5r)−5−((s)−3−アミノ−2−ヒドロキシプロプ−1−イル)−4−メトキシ−3−(フェニルスルホニルメチル)テトラヒドロフラン−2−イル)アセトアルデヒド誘導体およびこれらを調製するためのプロセス

Country Status (9)

Country Link
US (1) US9062020B2 (Direct)
EP (1) EP2797945B1 (Direct)
JP (1) JP6300030B2 (Direct)
CN (1) CN104080793B (Direct)
AU (1) AU2012363334B2 (Direct)
CA (1) CA2860446C (Direct)
IN (1) IN2014MN01521A (Direct)
SI (1) SI2797945T1 (Direct)
WO (1) WO2013097042A1 (Direct)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104053645A (zh) 2011-11-30 2014-09-17 阿方拉研究股份有限公司 用于制备(3r)-2,4-二-离去基团-3-甲基丁-1-烯的工艺
WO2013086634A1 (en) 2011-12-16 2013-06-20 Alphora Research Inc. Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl) propanol derivatives and intermediates useful thereof
CA2868627C (en) 2012-03-30 2021-02-16 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein
TW201617326A (zh) 2014-03-06 2016-05-16 Alphora研發股份有限公司 (s)-1-((2r,3r,4s,5s)-5-烯丙-3-甲氧-4-(對甲苯磺醯甲基)四氫呋喃-2-基)-3-氨基丙-2-醇之結晶衍生物
EP3160970A4 (en) 2014-06-30 2017-12-27 President and Fellows of Harvard College Synthesis of halichondrin analogs and uses thereof
US10147463B2 (en) 2014-12-10 2018-12-04 Nxp Usa, Inc. Video processing unit and method of buffering a source video stream
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
RU2754369C2 (ru) 2016-03-02 2021-09-01 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Конъюгаты антитело-лекарственное средство на основе эрибулина и способы применения
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
LT3606928T (lt) 2017-04-05 2022-12-12 President And Fellows Of Harvard College Makrociklinis junginys ir jo panaudojimo būdai
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
KR20220124279A (ko) 2017-07-06 2022-09-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 할리콘드린의 합성
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
WO2019099646A1 (en) 2017-11-15 2019-05-23 President And Fellows Of Harvard College Macrocyclic compounds and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
ES2209327T3 (es) 1993-07-09 2004-06-16 Laboratoire Theramex Nuevos analogos estructurales de la vitamina d.
PT1087960E (pt) 1998-06-17 2011-06-17 Eisai R&D Man Co Ltd Análogos macrocíclicos e métodos de sua utilização e preparação
US7001982B2 (en) 2003-03-31 2006-02-21 Council Of Scientific And Industrial Research Non-natural C-linked carbo-β-peptides with robust secondary structures
EP2949652B1 (en) * 2004-06-03 2019-08-07 Eisai R&D Management Co., Ltd. Intermediates for the preparation of halichondrin B
CA2822994C (en) * 2004-06-03 2016-09-27 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of halichondrin b
EP2274309B1 (en) * 2008-04-04 2015-07-29 Eisai R&D Management Co., Ltd. Halichondrin b analogs
CN104053645A (zh) 2011-11-30 2014-09-17 阿方拉研究股份有限公司 用于制备(3r)-2,4-二-离去基团-3-甲基丁-1-烯的工艺
WO2013086634A1 (en) 2011-12-16 2013-06-20 Alphora Research Inc. Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl) propanol derivatives and intermediates useful thereof
CA2868627C (en) 2012-03-30 2021-02-16 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein
TW201514159A (zh) 2013-05-15 2015-04-16 Alphora Res Inc 3-((2s,5s)-4-亞甲基-5-(3-氧代丙基)四氫呋喃-2-基)丙醇衍生物、其製備及對其有用的中間體

Also Published As

Publication number Publication date
JP2015503525A (ja) 2015-02-02
EP2797945B1 (en) 2016-03-16
EP2797945A4 (en) 2015-06-03
EP2797945A1 (en) 2014-11-05
CN104080793A (zh) 2014-10-01
AU2012363334A1 (en) 2014-08-21
CA2860446A1 (en) 2013-07-04
IN2014MN01521A (Direct) 2015-05-01
AU2012363334B2 (en) 2017-02-02
CN104080793B (zh) 2017-09-19
SI2797945T1 (sl) 2016-07-29
WO2013097042A1 (en) 2013-07-04
US9062020B2 (en) 2015-06-23
US20150011776A1 (en) 2015-01-08
CA2860446C (en) 2017-01-10

Similar Documents

Publication Publication Date Title
JP6300030B2 (ja) 2−((2s,3s,4r,5r)−5−((s)−3−アミノ−2−ヒドロキシプロプ−1−イル)−4−メトキシ−3−(フェニルスルホニルメチル)テトラヒドロフラン−2−イル)アセトアルデヒド誘導体およびこれらを調製するためのプロセス
JP6511613B2 (ja) ハリコンドリンBの大環状C1−ケト類似体の製造のための合成方法及び該方法に有用な中間体、例えば−SO2−(p−トリル)基を含有する中間体
AU2013239290B2 (en) Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein
CA2909209A1 (en) 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
BR112012018232B1 (pt) Compostos derivados de furo [3,2-b] pirano úteis na síntese de análogos de halicondrina b e métodos de sintetização de er-80402 e de eribulina
JP6528251B2 (ja) (s)−1−((2r,3r,4s,5s)−5−アリル−3−メトキシ−4−(トシルメチル)テトラヒドロフラン−2−イル)−3−アミノプロパン−2−オールの結晶性誘導体
CA3098164A1 (en) Process for preparation of advanced intermediate for eribulin synthesys

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151218

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160705

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161005

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170328

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170628

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170828

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170928

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180123

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20180214

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180214

R150 Certificate of patent or registration of utility model

Ref document number: 6300030

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees